Biotechnology Media Insights — White Paper Library

Guided by Vision: Redefining OSD Development Through Foresight and Innovation

Oral solid dosage form pharmaceutical tablets and capsules development
Oral Drug Development

Guided by Vision: Redefining OSD Development Through Foresight and Innovation

Bringing clarity to complexity in oral drug development.

Thermo Fisher Scientific Pharma ServicesBiotechnology Media Insights
Full White Paper Content

Mastering oral solid dose development requires strategic foresight and four key pillars: technology and expertise, global networks, customized services and regulatory excellence.

Technology and Expertise

Access to enabling technologies and experienced scientists allows teams to tackle poorly soluble and high-potency molecules.

Global Networks and Customized Services

A connected network of sites provides flexibility in capacity and geography, while tailored services match each program.

Regulatory Excellence

A strong regulatory track record supports faster, smoother submissions across regions.

About This White Paper

This white paper is published by Thermo Fisher Scientific Pharma Services and curated by Biotechnology Media Insights, a trusted source for pharmaceutical and biotechnology research, technical guides and industry analysis.

Published by Thermo Fisher Scientific Pharma Services · Curated by Biotechnology Media Insights

Pharmaceutical & Biotechnology White Papers | Biotechnology Media Insights